General Information of Drug (ID:
DR2066) |
Drug Name |
Methylthioadenosine
|
Synonyms |
S-methyl-5'-thioadenosine; Thiomethyladenosine; 5'-Methylthioadenosine; ADENOSINE, 5'-S-METHYL-5'-THIO-; Vitamin L(sub 2); Vitamin L2; (2R,3R,4S,5S)-2-(6-Amino-9H-purin-9-yl)-5-((methylthio)methyl)tetrahydrofuran-3,4-diol; 2457-80-9; 5'-(Methylthio)-5'-deoxyadenosine; 5'-(Methylthio)adenosine; 5'-DEOXY-5'-METHYLTHIOADENOSINE; 5'-Deoxy(methylthio)adenosine; 5'-Deoxy-5'-(methylthio)adenosine; 5'-S-Methylthioadenosine; 5'-S-methyl-5'-thioadenosine; 5'-methylthioadenosine; 5-Methylthioadenosine; MTA; NSC 335422; UNII-634Z2VK3UQ
|
Indication |
Multiple sclerosis
[ICD11: 8A40]
|
Investigative
|
[1]
|
Structure |
|
|
3D MOL
|
2D MOL
|
Pharmaceutical Properties |
Molecular Weight |
297.34 |
Topological Polar Surface Area |
145 |
Heavy Atom Count |
20 |
Rotatable Bond Count |
3 |
Hydrogen Bond Donor Count |
3 |
Hydrogen Bond Acceptor Count |
8 |
Cross-matching ID |
- PubChem CID
- 439176
- ChEBI ID
-
- CAS Number
-
- TTD Drug ID
- D0E4WF
- Formula
- C11H15N5O3S
- Canonical SMILES
- CSCC1C(C(C(O1)N2C=NC3=C2N=CN=C3N)O)O
- InChI
- 1S/C11H15N5O3S/c1-20-2-5-7(17)8(18)11(19-5)16-4-15-6-9(12)13-3-14-10(6)16/h3-5,7-8,11,17-18H,2H2,1H3,(H2,12,13,14)/t5-,7-,8-,11-/m1/s1
- InChIKey
- WUUGFSXJNOTRMR-IOSLPCCCSA-N
|
|
|
|
|
|
|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.